Structure

Physi-Chem Properties

Molecular Weight:  334.17
Volume:  338.269
LogP:  1.775
LogD:  1.855
LogS:  -2.592
# Rotatable Bonds:  0
TPSA:  32.78
# H-Bond Aceptor:  4
# H-Bond Donor:  0
# Rings:  7
# Heavy Atoms:  4

MedChem Properties

QED Drug-Likeness Score:  0.681
Synthetic Accessibility Score:  5.723
Fsp3:  0.571
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Accepted
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.684
MDCK Permeability:  5.542056533158757e-05
Pgp-inhibitor:  0.768
Pgp-substrate:  0.002
Human Intestinal Absorption (HIA):  0.087
20% Bioavailability (F20%):  0.323
30% Bioavailability (F30%):  0.801

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.992
Plasma Protein Binding (PPB):  55.78098678588867%
Volume Distribution (VD):  2.18
Pgp-substrate:  41.581912994384766%

ADMET: Metabolism

CYP1A2-inhibitor:  0.021
CYP1A2-substrate:  0.672
CYP2C19-inhibitor:  0.065
CYP2C19-substrate:  0.936
CYP2C9-inhibitor:  0.06
CYP2C9-substrate:  0.419
CYP2D6-inhibitor:  0.036
CYP2D6-substrate:  0.572
CYP3A4-inhibitor:  0.184
CYP3A4-substrate:  0.918

ADMET: Excretion

Clearance (CL):  17.303
Half-life (T1/2):  0.061

ADMET: Toxicity

hERG Blockers:  0.018
Human Hepatotoxicity (H-HT):  0.137
Drug-inuced Liver Injury (DILI):  0.058
AMES Toxicity:  0.033
Rat Oral Acute Toxicity:  0.947
Maximum Recommended Daily Dose:  0.923
Skin Sensitization:  0.074
Carcinogencity:  0.964
Eye Corrosion:  0.003
Eye Irritation:  0.009
Respiratory Toxicity:  0.882

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC214626

Natural Product ID:  NPC214626
Common Name*:   4A,5,5A,7,8,13A,15,15A,15B,16-Decahydro-2H-4,6-Methanoindolo[3,2,1-Ij]Oxepino[2,3,4-De]Pyrrolo[2,3-H]Quinoline-14-One
IUPAC Name:   4a,5,5a,7,8,13a,15,15a,15b,16-decahydro-2H-4,6-methanoindolo[3,2,1-ij]oxepino[2,3,4-de]pyrrolo[2,3-h]quinoline-14-one
Synonyms:  
Standard InCHIKey:  QMGVPVSNSZLJIA-UHFFFAOYSA-N
Standard InCHI:  InChI=1S/C21H22N2O2/c24-18-10-16-19-13-9-17-21(6-7-22(17)11-12(13)5-8-25-16)14-3-1-2-4-15(14)23(18)20(19)21/h1-5,13,16-17,19-20H,6-11H2
SMILES:  c1ccc2c(c1)C13CCN4CC5=CCOC6CC(=O)N2C3C6C5CC14
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL1609139
PubChem CID:   5304
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000279] Alkaloids and derivatives
      • [CHEMONTID:0002749] Strychnos alkaloids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO6067 Strychnos ignatii Species Loganiaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO6067 Strychnos ignatii Species Loganiaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO6067 Strychnos ignatii Species Loganiaceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]
NPO6067 Strychnos ignatii Species Loganiaceae Eukaryota n.a. n.a. n.a. Database[TM-MC]
NPO6067 Strychnos ignatii Species Loganiaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT443 Individual Protein Histone acetyltransferase GCN5 Homo sapiens Potency n.a. 4466.8 nM PMID[544313]
NPT197 Protein-Protein Interaction Menin/Histone-lysine N-methyltransferase MLL Homo sapiens Potency = 5011.9 nM PMID[544313]
NPT2 Others Unspecified Potency n.a. 7079.5 nM PMID[544313]
NPT20556 SINGLE PROTEIN Replicase polyprotein 1ab Severe acute respiratory syndrome coronavirus 2 Inhibition = -9.3 % PMID[544314]
NPT20555 ORGANISM SARS-CoV-2 Severe acute respiratory syndrome coronavirus 2 Inhibition = -0.02 % PMID[544315]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC214626 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC139085
1.0 High Similarity NPC251212
0.9563 High Similarity NPC260075
0.9226 High Similarity NPC22689
0.9226 High Similarity NPC105055
0.8908 High Similarity NPC162440
0.8788 High Similarity NPC96901
0.8757 High Similarity NPC67904
0.8757 High Similarity NPC138830
0.8564 High Similarity NPC329833
0.8528 High Similarity NPC225319
0.8519 High Similarity NPC113946
0.8263 Intermediate Similarity NPC472106
0.8253 Intermediate Similarity NPC282339
0.8253 Intermediate Similarity NPC99632
0.8148 Intermediate Similarity NPC159815
0.8144 Intermediate Similarity NPC472120
0.8144 Intermediate Similarity NPC472101
0.814 Intermediate Similarity NPC264482
0.814 Intermediate Similarity NPC203202
0.8121 Intermediate Similarity NPC29285
0.8084 Intermediate Similarity NPC248117
0.8024 Intermediate Similarity NPC193410
0.7964 Intermediate Similarity NPC61013
0.7931 Intermediate Similarity NPC320147
0.7929 Intermediate Similarity NPC472117
0.7921 Intermediate Similarity NPC52262
0.7919 Intermediate Similarity NPC473743
0.7895 Intermediate Similarity NPC214960
0.7895 Intermediate Similarity NPC279527
0.7857 Intermediate Similarity NPC10653
0.7857 Intermediate Similarity NPC318525
0.7849 Intermediate Similarity NPC223595
0.7849 Intermediate Similarity NPC224970
0.7849 Intermediate Similarity NPC167724
0.7841 Intermediate Similarity NPC99043
0.7841 Intermediate Similarity NPC218594
0.7841 Intermediate Similarity NPC6974
0.7824 Intermediate Similarity NPC176983
0.7824 Intermediate Similarity NPC286871
0.7809 Intermediate Similarity NPC159963
0.7784 Intermediate Similarity NPC186669
0.7772 Intermediate Similarity NPC221687
0.7765 Intermediate Similarity NPC309531
0.7765 Intermediate Similarity NPC472102
0.7764 Intermediate Similarity NPC22082
0.7764 Intermediate Similarity NPC186284
0.7751 Intermediate Similarity NPC123241
0.7719 Intermediate Similarity NPC293458
0.7714 Intermediate Similarity NPC476425
0.7705 Intermediate Similarity NPC25401
0.7701 Intermediate Similarity NPC469915
0.7679 Intermediate Similarity NPC478076
0.7665 Intermediate Similarity NPC243756
0.7637 Intermediate Similarity NPC14994
0.7636 Intermediate Similarity NPC264589
0.7602 Intermediate Similarity NPC36495
0.754 Intermediate Similarity NPC97100
0.754 Intermediate Similarity NPC473375
0.7529 Intermediate Similarity NPC475420
0.7529 Intermediate Similarity NPC473297
0.7529 Intermediate Similarity NPC471124
0.7528 Intermediate Similarity NPC476441
0.7527 Intermediate Similarity NPC259626
0.7526 Intermediate Similarity NPC471512
0.7473 Intermediate Similarity NPC97584
0.7473 Intermediate Similarity NPC473004
0.7473 Intermediate Similarity NPC2933
0.7472 Intermediate Similarity NPC329338
0.7472 Intermediate Similarity NPC469726
0.7457 Intermediate Similarity NPC143457
0.7446 Intermediate Similarity NPC21425
0.7418 Intermediate Similarity NPC256288
0.7416 Intermediate Similarity NPC285622
0.7416 Intermediate Similarity NPC473880
0.7412 Intermediate Similarity NPC122106
0.7407 Intermediate Similarity NPC471123
0.7403 Intermediate Similarity NPC11149
0.7403 Intermediate Similarity NPC286994
0.7399 Intermediate Similarity NPC471122
0.7389 Intermediate Similarity NPC476326
0.7366 Intermediate Similarity NPC473298
0.7356 Intermediate Similarity NPC474058
0.7353 Intermediate Similarity NPC475763
0.7353 Intermediate Similarity NPC66936
0.7348 Intermediate Similarity NPC321211
0.7345 Intermediate Similarity NPC475248
0.7345 Intermediate Similarity NPC63047
0.7337 Intermediate Similarity NPC473007
0.7337 Intermediate Similarity NPC322621
0.7323 Intermediate Similarity NPC10732
0.7314 Intermediate Similarity NPC469741
0.7306 Intermediate Similarity NPC473005
0.7297 Intermediate Similarity NPC473615
0.7292 Intermediate Similarity NPC475489
0.7288 Intermediate Similarity NPC472114
0.7288 Intermediate Similarity NPC472115
0.7286 Intermediate Similarity NPC473006
0.7283 Intermediate Similarity NPC469536
0.7277 Intermediate Similarity NPC100863
0.7277 Intermediate Similarity NPC288110
0.7258 Intermediate Similarity NPC229484
0.7258 Intermediate Similarity NPC181928
0.7257 Intermediate Similarity NPC201424
0.7251 Intermediate Similarity NPC154602
0.7249 Intermediate Similarity NPC470485
0.7228 Intermediate Similarity NPC477159
0.7225 Intermediate Similarity NPC161827
0.7219 Intermediate Similarity NPC292675
0.7211 Intermediate Similarity NPC243626
0.7211 Intermediate Similarity NPC230313
0.7211 Intermediate Similarity NPC34717
0.7182 Intermediate Similarity NPC13367
0.7181 Intermediate Similarity NPC473008
0.7176 Intermediate Similarity NPC212799
0.7174 Intermediate Similarity NPC476428
0.7169 Intermediate Similarity NPC130251
0.7166 Intermediate Similarity NPC285841
0.716 Intermediate Similarity NPC116519
0.7159 Intermediate Similarity NPC315368
0.7151 Intermediate Similarity NPC476095
0.7143 Intermediate Similarity NPC77777
0.7143 Intermediate Similarity NPC470483
0.7135 Intermediate Similarity NPC90967
0.7111 Intermediate Similarity NPC472118
0.7108 Intermediate Similarity NPC469560
0.7102 Intermediate Similarity NPC310403
0.7102 Intermediate Similarity NPC243673
0.7102 Intermediate Similarity NPC97380
0.7102 Intermediate Similarity NPC148468
0.7102 Intermediate Similarity NPC63210
0.7102 Intermediate Similarity NPC263709
0.7093 Intermediate Similarity NPC473329
0.709 Intermediate Similarity NPC473569
0.7059 Intermediate Similarity NPC472107
0.7059 Intermediate Similarity NPC79062
0.7056 Intermediate Similarity NPC33507
0.7053 Intermediate Similarity NPC22476
0.7053 Intermediate Similarity NPC203628
0.7045 Intermediate Similarity NPC222029
0.7041 Intermediate Similarity NPC162730
0.7041 Intermediate Similarity NPC52801
0.7039 Intermediate Similarity NPC52059
0.7039 Intermediate Similarity NPC470069
0.7033 Intermediate Similarity NPC276993
0.7033 Intermediate Similarity NPC181138
0.7033 Intermediate Similarity NPC298851
0.7033 Intermediate Similarity NPC293255
0.7033 Intermediate Similarity NPC21752
0.7033 Intermediate Similarity NPC210415
0.7033 Intermediate Similarity NPC473458
0.7026 Intermediate Similarity NPC127178
0.7011 Intermediate Similarity NPC285381
0.7 Intermediate Similarity NPC5630
0.6995 Remote Similarity NPC475097
0.6995 Remote Similarity NPC470548
0.6964 Remote Similarity NPC243162
0.6954 Remote Similarity NPC1464
0.6954 Remote Similarity NPC474116
0.6949 Remote Similarity NPC153694
0.6949 Remote Similarity NPC104345
0.6949 Remote Similarity NPC211525
0.6947 Remote Similarity NPC284706
0.6942 Remote Similarity NPC222046
0.694 Remote Similarity NPC307640
0.6936 Remote Similarity NPC242000
0.6923 Remote Similarity NPC301760
0.6915 Remote Similarity NPC245741
0.6907 Remote Similarity NPC303214
0.6897 Remote Similarity NPC127996
0.6893 Remote Similarity NPC477157
0.6893 Remote Similarity NPC477156
0.6885 Remote Similarity NPC355
0.6881 Remote Similarity NPC126066
0.6878 Remote Similarity NPC234772
0.6872 Remote Similarity NPC471513
0.685 Remote Similarity NPC477173
0.685 Remote Similarity NPC477161
0.685 Remote Similarity NPC246140
0.685 Remote Similarity NPC195787
0.6842 Remote Similarity NPC469537
0.6842 Remote Similarity NPC308197
0.6842 Remote Similarity NPC282092
0.6839 Remote Similarity NPC109787
0.6837 Remote Similarity NPC132874
0.6837 Remote Similarity NPC138615
0.6837 Remote Similarity NPC218733
0.6837 Remote Similarity NPC265642
0.6834 Remote Similarity NPC477179
0.6833 Remote Similarity NPC85651
0.6833 Remote Similarity NPC472121
0.6825 Remote Similarity NPC472119
0.6824 Remote Similarity NPC470301
0.6821 Remote Similarity NPC472100
0.6818 Remote Similarity NPC232600
0.6816 Remote Similarity NPC470488
0.6813 Remote Similarity NPC278887
0.68 Remote Similarity NPC477178
0.68 Remote Similarity NPC254850
0.68 Remote Similarity NPC87714

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC214626 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.7318 Intermediate Similarity NPD5997 Discontinued
0.7134 Intermediate Similarity NPD4775 Clinical (unspecified phase)
0.7101 Intermediate Similarity NPD7487 Discontinued
0.7083 Intermediate Similarity NPD6566 Discontinued
0.6977 Remote Similarity NPD7794 Clinical (unspecified phase)
0.6971 Remote Similarity NPD4121 Phase 3
0.6971 Remote Similarity NPD4120 Approved
0.6932 Remote Similarity NPD5741 Approved
0.6932 Remote Similarity NPD5742 Approved
0.6932 Remote Similarity NPD5743 Approved
0.6854 Remote Similarity NPD5715 Clinical (unspecified phase)
0.6818 Remote Similarity NPD8400 Approved
0.6818 Remote Similarity NPD8401 Approved
0.6818 Remote Similarity NPD8402 Approved
0.6806 Remote Similarity NPD8103 Clinical (unspecified phase)
0.6802 Remote Similarity NPD6661 Clinical (unspecified phase)
0.6802 Remote Similarity NPD5918 Discontinued
0.6771 Remote Similarity NPD6608 Clinical (unspecified phase)
0.6768 Remote Similarity NPD6805 Discontinued
0.6755 Remote Similarity NPD6878 Phase 2
0.6755 Remote Similarity NPD6879 Phase 2
0.6722 Remote Similarity NPD7599 Phase 2
0.672 Remote Similarity NPD3423 Phase 2
0.672 Remote Similarity NPD3422 Phase 3
0.6707 Remote Similarity NPD6740 Clinical (unspecified phase)
0.6702 Remote Similarity NPD6021 Clinical (unspecified phase)
0.6685 Remote Similarity NPD7600 Phase 2
0.6684 Remote Similarity NPD5620 Clinical (unspecified phase)
0.6683 Remote Similarity NPD4601 Approved
0.6683 Remote Similarity NPD4600 Approved
0.6667 Remote Similarity NPD7295 Approved
0.6667 Remote Similarity NPD5931 Phase 3
0.6667 Remote Similarity NPD5932 Phase 3
0.6667 Remote Similarity NPD5933 Phase 3
0.6667 Remote Similarity NPD7606 Phase 3
0.665 Remote Similarity NPD6238 Discontinued
0.6649 Remote Similarity NPD5600 Discontinued
0.6617 Remote Similarity NPD5721 Clinical (unspecified phase)
0.6604 Remote Similarity NPD6995 Phase 1
0.6592 Remote Similarity NPD2790 Discontinued
0.6591 Remote Similarity NPD7478 Approved
0.659 Remote Similarity NPD6768 Approved
0.6584 Remote Similarity NPD7205 Discontinued
0.6568 Remote Similarity NPD5184 Approved
0.6568 Remote Similarity NPD5185 Approved
0.6568 Remote Similarity NPD5182 Approved
0.6566 Remote Similarity NPD4549 Discontinued
0.6561 Remote Similarity NPD5179 Approved
0.6561 Remote Similarity NPD5181 Approved
0.6561 Remote Similarity NPD5180 Approved
0.6554 Remote Similarity NPD5941 Approved
0.6554 Remote Similarity NPD5942 Approved
0.6554 Remote Similarity NPD4682 Phase 2
0.6552 Remote Similarity NPD4430 Phase 2
0.6552 Remote Similarity NPD2820 Phase 3
0.6552 Remote Similarity NPD7082 Approved
0.655 Remote Similarity NPD6358 Phase 2
0.655 Remote Similarity NPD2670 Approved
0.6543 Remote Similarity NPD5919 Clinical (unspecified phase)
0.6522 Remote Similarity NPD6533 Clinical (unspecified phase)
0.6519 Remote Similarity NPD1663 Discontinued
0.6517 Remote Similarity NPD4501 Approved
0.6517 Remote Similarity NPD4500 Approved
0.6514 Remote Similarity NPD7259 Approved
0.6494 Remote Similarity NPD2365 Approved
0.6492 Remote Similarity NPD6654 Clinical (unspecified phase)
0.6488 Remote Similarity NPD6489 Phase 3
0.6485 Remote Similarity NPD6321 Discontinued
0.6484 Remote Similarity NPD8630 Approved
0.6474 Remote Similarity NPD5312 Approved
0.6474 Remote Similarity NPD5313 Approved
0.6471 Remote Similarity NPD5183 Approved
0.6471 Remote Similarity NPD5186 Approved
0.6471 Remote Similarity NPD3376 Clinical (unspecified phase)
0.6455 Remote Similarity NPD6316 Clinical (unspecified phase)
0.6448 Remote Similarity NPD5294 Clinical (unspecified phase)
0.6447 Remote Similarity NPD5504 Discontinued
0.644 Remote Similarity NPD5900 Clinical (unspecified phase)
0.6437 Remote Similarity NPD3625 Discontinued
0.6429 Remote Similarity NPD4334 Discontinued
0.6429 Remote Similarity NPD4365 Phase 2
0.6422 Remote Similarity NPD7064 Clinical (unspecified phase)
0.6417 Remote Similarity NPD6457 Approved
0.6402 Remote Similarity NPD3377 Discontinued
0.6396 Remote Similarity NPD4499 Approved
0.6393 Remote Similarity NPD7735 Clinical (unspecified phase)
0.6393 Remote Similarity NPD7688 Phase 1
0.6387 Remote Similarity NPD5521 Clinical (unspecified phase)
0.6386 Remote Similarity NPD5136 Clinical (unspecified phase)
0.6384 Remote Similarity NPD6622 Phase 1
0.6384 Remote Similarity NPD6017 Discontinued
0.6378 Remote Similarity NPD6891 Phase 2
0.6377 Remote Similarity NPD2916 Discontinued
0.6369 Remote Similarity NPD4644 Clinical (unspecified phase)
0.6369 Remote Similarity NPD5881 Clinical (unspecified phase)
0.6364 Remote Similarity NPD7595 Discontinued
0.6364 Remote Similarity NPD3622 Clinical (unspecified phase)
0.6364 Remote Similarity NPD5823 Approved
0.6364 Remote Similarity NPD5024 Approved
0.6364 Remote Similarity NPD3623 Clinical (unspecified phase)
0.6364 Remote Similarity NPD6567 Clinical (unspecified phase)
0.6359 Remote Similarity NPD6557 Phase 2
0.6358 Remote Similarity NPD2569 Approved
0.6358 Remote Similarity NPD2567 Approved
0.6349 Remote Similarity NPD5727 Clinical (unspecified phase)
0.6345 Remote Similarity NPD8025 Phase 2
0.6343 Remote Similarity NPD2093 Discontinued
0.6339 Remote Similarity NPD6855 Clinical (unspecified phase)
0.6339 Remote Similarity NPD6396 Clinical (unspecified phase)
0.6339 Remote Similarity NPD6395 Phase 2
0.6337 Remote Similarity NPD2791 Discontinued
0.6335 Remote Similarity NPD5603 Clinical (unspecified phase)
0.6331 Remote Similarity NPD5131 Approved
0.6324 Remote Similarity NPD2506 Approved
0.6322 Remote Similarity NPD3170 Approved
0.6322 Remote Similarity NPD6655 Clinical (unspecified phase)
0.6321 Remote Similarity NPD4330 Approved
0.6321 Remote Similarity NPD4329 Approved
0.6313 Remote Similarity NPD1802 Approved
0.6313 Remote Similarity NPD1801 Approved
0.6312 Remote Similarity NPD3551 Approved
0.631 Remote Similarity NPD7036 Phase 3
0.631 Remote Similarity NPD5993 Phase 1
0.631 Remote Similarity NPD7035 Approved
0.631 Remote Similarity NPD7591 Clinical (unspecified phase)
0.6302 Remote Similarity NPD3792 Approved
0.6301 Remote Similarity NPD6102 Clinical (unspecified phase)
0.6296 Remote Similarity NPD5991 Approved
0.6296 Remote Similarity NPD5990 Approved
0.6296 Remote Similarity NPD7795 Phase 2
0.6294 Remote Similarity NPD6483 Approved
0.6294 Remote Similarity NPD6484 Approved
0.6289 Remote Similarity NPD3471 Approved
0.6289 Remote Similarity NPD7149 Clinical (unspecified phase)
0.6289 Remote Similarity NPD3470 Approved
0.6287 Remote Similarity NPD3828 Approved
0.6286 Remote Similarity NPD5068 Clinical (unspecified phase)
0.6284 Remote Similarity NPD7186 Phase 3
0.6283 Remote Similarity NPD7449 Clinical (unspecified phase)
0.6281 Remote Similarity NPD8240 Discontinued
0.628 Remote Similarity NPD7174 Clinical (unspecified phase)
0.6277 Remote Similarity NPD8002 Clinical (unspecified phase)
0.6277 Remote Similarity NPD8003 Clinical (unspecified phase)
0.6273 Remote Similarity NPD7824 Approved
0.6271 Remote Similarity NPD4464 Clinical (unspecified phase)
0.6269 Remote Similarity NPD2869 Clinical (unspecified phase)
0.6269 Remote Similarity NPD4602 Approved
0.6267 Remote Similarity NPD8017 Clinical (unspecified phase)
0.6267 Remote Similarity NPD8016 Phase 3
0.6264 Remote Similarity NPD6342 Discontinued
0.6262 Remote Similarity NPD6176 Phase 1
0.6258 Remote Similarity NPD6343 Approved
0.6258 Remote Similarity NPD6345 Approved
0.6258 Remote Similarity NPD2994 Approved
0.6257 Remote Similarity NPD3141 Discontinued
0.6257 Remote Similarity NPD3790 Phase 2
0.6256 Remote Similarity NPD5071 Phase 2
0.6256 Remote Similarity NPD8658 Clinical (unspecified phase)
0.625 Remote Similarity NPD6518 Discontinued
0.625 Remote Similarity NPD2010 Phase 3
0.625 Remote Similarity NPD4315 Phase 2
0.6244 Remote Similarity NPD5444 Phase 1
0.6243 Remote Similarity NPD7126 Discontinued
0.6242 Remote Similarity NPD1721 Clinical (unspecified phase)
0.6237 Remote Similarity NPD6293 Clinical (unspecified phase)
0.6237 Remote Similarity NPD6454 Clinical (unspecified phase)
0.6231 Remote Similarity NPD5896 Clinical (unspecified phase)
0.623 Remote Similarity NPD6357 Discontinued
0.623 Remote Similarity NPD5086 Approved
0.623 Remote Similarity NPD7612 Clinical (unspecified phase)
0.623 Remote Similarity NPD7854 Phase 2
0.6228 Remote Similarity NPD6025 Phase 1
0.6223 Remote Similarity NPD5430 Discontinued
0.622 Remote Similarity NPD8027 Approved
0.622 Remote Similarity NPD7666 Phase 3
0.622 Remote Similarity NPD7665 Phase 2
0.6218 Remote Similarity NPD5334 Clinical (unspecified phase)
0.6218 Remote Similarity NPD3449 Discontinued
0.6207 Remote Similarity NPD7572 Phase 2
0.6203 Remote Similarity NPD4116 Approved
0.6202 Remote Similarity NPD7001 Phase 3
0.6202 Remote Similarity NPD4901 Clinical (unspecified phase)
0.6202 Remote Similarity NPD6732 Clinical (unspecified phase)
0.62 Remote Similarity NPD6659 Phase 2
0.6196 Remote Similarity NPD2638 Clinical (unspecified phase)
0.6196 Remote Similarity NPD2116 Approved
0.6196 Remote Similarity NPD2117 Pre-registration
0.6196 Remote Similarity NPD7072 Phase 2
0.6196 Remote Similarity NPD2115 Approved
0.619 Remote Similarity NPD6792 Phase 3
0.619 Remote Similarity NPD5578 Approved
0.619 Remote Similarity NPD5577 Clinical (unspecified phase)
0.6188 Remote Similarity NPD7950 Approved
0.6188 Remote Similarity NPD7528 Approved
0.6188 Remote Similarity NPD7952 Approved
0.6188 Remote Similarity NPD7953 Approved
0.6188 Remote Similarity NPD7791 Approved
0.6188 Remote Similarity NPD7789 Approved
0.6188 Remote Similarity NPD7951 Approved
0.6188 Remote Similarity NPD7790 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data